The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
there is a family of proteins called the bcl-2 family they come in different flavors there are the B co2 like proteins which inhibit apoptosis so they keep tumor cells alive and B co2 is a prototypical member of that family and is upregulated and amplified in translocated in many cancers to do exactly that and there are antagonize errs of B co2 and it's related proteins these are called the bh3 only proteins and they are often activated to inhibit B co2 to trigger apoptosis
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.